MorphoSys AG has acquired Lanthio Pharma BV of the Netherlands, a company with technology that can be used to identify peptides which are selective for a specific disease target and stabilise them for receptor binding. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
